Colin Broom
2017
In 2017, Colin Broom earned a total compensation of $1.9M as Chief Executive Officer at Nabriva Therapeutics AG, a 64% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $183,501 |
|---|---|
| Option Awards | $1,235,835 |
| Salary | $457,387 |
| Other | $40,158 |
| Total | $1,916,881 |
Broom received $1.2M in option awards, accounting for 64% of the total pay in 2017.
Broom also received $183.5K in non-equity incentive plan, $457.4K in salary and $40.2K in other compensation.
Rankings
In 2017, Colin Broom's compensation ranked 5,710th out of 14,666 executives tracked by ExecPay. In other words, Broom earned more than 61.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,710 out of 14,666 | 61st |
Division Manufacturing | 2,072 out of 5,768 | 64th |
Major group Chemicals And Allied Products | 642 out of 2,074 | 69th |
Industry group Drugs | 494 out of 1,730 | 71st |
Industry Pharmaceutical Preparations | 389 out of 1,329 | 71st |
Source: SEC filing on June 19, 2018.
Broom's colleagues
We found three more compensation records of executives who worked with Colin Broom at Nabriva Therapeutics AG in 2017.